Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions.
about
Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysisCombining Time-Driven Activity-Based Costing with Clinical Outcome in Cost-Effectiveness Analysis to Measure Value in Treatment of DepressionCost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country--the case of TanzaniaPlant stanol esters are potentially cost-effective in the prevention of coronary heart disease in men: Bayesian modelling approachCost-effectiveness of the School-Based Asthma Therapy (SBAT) programCost-effectiveness of intermittent preventive treatment of malaria in pregnancy in southern MozambiqueEconomic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancyCost-Effectiveness Analysis of Test-Based versus Presumptive Treatment of Uncomplicated Malaria in Children under Five Years in an Area of High Transmission in Central GhanaImplementation of a Multicomponent intervention to Prevent Physical Restraints In Nursing home residenTs (IMPRINT): study protocol for a cluster-randomised controlled trialGuided and unguided internet-based vestibular rehabilitation versus usual care for dizzy adults of 50 years and older: a protocol for a three-armed randomised trialEconomic Evaluation of Individual School Closure Strategies: The Hong Kong 2009 H1N1 Pandemic.Treatment strategies for pelvic organ prolapse: a cost-effectiveness analysis.Cost-effectiveness of a vocational enablement protocol for employees with hearing impairment; design of a randomized controlled trialEvaluating the effectiveness of using personal tailored risk information and taster sessions to increase the uptake of smoking cessation services: study protocol for a randomised controlled trial.Cost-effectiveness of a stepped-care intervention to prevent major depression in patients with type 2 diabetes mellitus and/or coronary heart disease and subthreshold depression: design of a cluster-randomized controlled trial.Evaluating the efficacy and cost-effectiveness of web-based indicated prevention of major depression: design of a randomised controlled trialCost-effectiveness of a multifaceted implementation strategy for the Dutch multidisciplinary guideline for nonspecific low back pain: design of a stepped-wedge cluster randomised controlled trial.Methods to construct a step-by-step beginner's guide to decision analytic cost-effectiveness modeling.Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation.Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope.Methods of data collection and analysis for the economic evaluation alongside a national, multi-centre trial in the UK: conventional ventilation or ECMO for Severe Adult Respiratory Failure (CESAR)Health economic evaluation in lumbar spinal fusion: a systematic literature review anno 2005.Clinical and cost-effectiveness of computerised cognitive behavioural therapy for depression in primary care: design of a randomised trial.Cost-effectiveness analysis of cognitive behaviour therapy for treatment of minor or mild-major depression in elderly patients with type 2 diabetes: study protocol for the economic evaluation alongside the MIND-DIA randomized controlled trial (MIND-Activity Increase Despite Arthritis (AIDA): design of a Phase II randomised controlled trial evaluating an active management booklet for hip and knee osteoarthritis [ISRCTN24554946]Cost-effectiveness of a telephone-delivered intervention for physical activity and dietCost-effectiveness of an intervention to reduce emergency re-admissions to hospital among older patients.The incremental cost-effectiveness of engaging private practitioners to refer tuberculosis suspects to DOTS services in Jogjakarta, Indonesia.Statistical analysis of cost-effectiveness data from randomized clinical trials.Cost-effectiveness of a transitional pharmaceutical care program for patients discharged from the hospital.Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules.Cost-effectiveness analysis of malaria rapid diagnostic tests for appropriate treatment of malaria at the community level in UgandaCost-effectiveness of skin-barrier-enhancing emollients among preterm infants in Bangladesh.Living Well with Diabetes: a randomized controlled trial of a telephone-delivered intervention for maintenance of weight loss, physical activity and glycaemic control in adults with type 2 diabetes.Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients.The SITLESS project: exercise referral schemes enhanced by self-management strategies to battle sedentary behaviour in older adults: study protocol for a randomised controlled trial.Trial-based economic evaluations in occupational health: principles, methods, and recommendationsWithin-trial economic evaluation of diabetes-specific cognitive behaviour therapy in patients with type 2 diabetes and subthreshold depressionA pragmatic multi-centred randomised controlled trial of yoga for chronic low back pain: trial protocolCost effectiveness of home ultraviolet B phototherapy for psoriasis: economic evaluation of a randomised controlled trial (PLUTO study).
P2860
Q26779489-93660846-0C54-419D-AD18-5FE8460E6638Q28109665-A0F3E928-1452-41FD-B10D-74F48719DD12Q28219296-90820F0F-01C7-4303-83CF-FE0B49474574Q28298648-9754AB2A-C1AC-4074-8C6E-7A2D4171F7F0Q28394885-EC7CFF8E-E679-41F7-90EC-5402693B4AC0Q28475795-5FEE8875-A0AF-407C-B4ED-3042E9D3CA6DQ28546725-9E6F59D3-940A-4B2A-AA26-EAC4E3AD6855Q28554436-8C721D06-CFE6-4199-B6E5-FDA4B7204455Q30316348-FDC353C7-3B7F-4969-A5A5-95659885FB53Q30365019-BADD0510-9A1C-41D2-812C-0201228E0378Q30383964-A4EBB7A6-008F-4AB8-B721-8096FA8D73E7Q30452961-55FA5081-5B77-4D07-8ABA-6703548CAE3CQ30469499-D405E9AB-0F4F-46D7-A6F1-146E3EA7980FQ30534396-7BF9D7AA-61A4-4A03-A4CD-8B66BFF224DBQ30539810-C905E1FF-D93A-41FC-847D-79960D9295C2Q30570969-25469578-27A9-4B9B-B319-83DA6CB139D2Q30652432-704FAD61-10FA-46B0-8C75-E1F92479191DQ30823226-F404CF45-4296-4DD9-B29E-62EDCDD26FB6Q31037061-A847EBD3-2AB0-4554-B2FB-D336B7C5F51AQ31043509-21EF0BE0-F46A-4ABA-BAA2-53598D0F8D4EQ31154043-F4AA0E17-181F-41C8-A2E6-596A76C80F74Q33230071-9F259487-19F4-4DFA-8482-AF883DB0B925Q33347829-AECED5E4-91BD-4150-956A-BA9F32CAC7FBQ33477135-0BA54F5F-1723-4049-9920-74CAE70F9B7EQ33500332-1620F6D8-CC51-4951-B374-C929148E61DAQ33506631-00A64566-B28E-4F00-8686-664D3264F3EDQ33510685-218DF740-A4B6-4767-95EA-D44C788A0731Q33592697-8E6545BD-60D9-4301-A3D9-17B588DC4312Q33596439-1798E3B5-7487-460F-9F41-334AF9ED53D4Q33606014-8BF877FA-C5DB-4184-9311-1DCCB9D55064Q33606843-733B22A4-67E3-4092-8DEF-4FC4C12965EDQ33608173-F5FD65FD-C1DE-42CE-AB05-5419E4CB6FBCQ33623123-898EC520-B1F4-49F5-B943-9F079F14D089Q33647443-4534825E-E206-40B2-B7B1-BB5CB2227E32Q33652027-71889A0F-7371-4C8C-91BB-0527D7814997Q33705908-9C2C9BC9-5BE1-41B1-A2D3-74E02BA04FADQ33718157-B4C54921-0F62-48E1-B11F-36F4DEA11CBDQ33722817-D0DBDD47-A0B4-422F-8176-83DAB9C1B458Q33799041-AA583A35-1736-475D-87E1-A4D9239DC02AQ33802843-8D39D315-6479-469E-8AEA-22415D49359E
P2860
Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions.
@ast
Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions.
@en
type
label
Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions.
@ast
Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions.
@en
prefLabel
Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions.
@ast
Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions.
@en
P2093
P356
P1433
P1476
Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions.
@en
P2093
Andrew Briggs
Bernie J O'Brien
Elisabeth Fenwick
P304
P356
10.1002/HEC.903
P407
P577
2004-05-01T00:00:00Z